Provided by Tiger Trade Technology Pte. Ltd.

GeneDx Holdings

94.78
+3.543.88%
Pre-market: 97.993.21+3.39%08:44 EST
Volume:950.81K
Turnover:89.56M
Market Cap:2.74B
PE:1.29K
High:95.22
Open:91.24
Low:91.24
Close:91.24
52wk High:170.87
52wk Low:55.17
Shares:28.90M
Float Shares:19.94M
Volume Ratio:1.01
T/O Rate:4.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0735
EPS(LYR):-1.9444
ROE:0.84%
ROA:1.61%
PB:9.37
PE(LYR):-48.75

Loading ...

Wells Fargo Upgrades GeneDx Holdings to Overweight From Equalweight

MT Newswires Live
·
Feb 09

GeneDx Holdings Corp. : Wells Fargo Raises to Overweight From Equal Weight

THOMSON REUTERS
·
Feb 09

U.S. RESEARCH ROUNDUP-Align Technology, Biogen, Citigroup

Reuters
·
Feb 09

GeneDx COO Bryan Dechairo Reports Disposal of Common Shares

Reuters
·
Feb 07

GeneDx Holdings Corp. to Release Fourth Quarter Financial Results

Reuters
·
Feb 03

Analysts Are Bullish on Top Healthcare Stocks: Immutep Ltd (PRRUF), GeneDx Holdings (WGS)

TIPRANKS
·
Feb 02

Cathie Wood’s ARK Investment buys 91.8K shares of GeneDx today

TIPRANKS
·
Jan 31

Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data

GlobeNewswire
·
Jan 27

GeneDx Holdings (WGS) Valuation After Strong 2025 Outlook And New Genomics Growth Initiatives

Simply Wall St.
·
Jan 16

Health Minister Responds to Reports of Two Super Flu Cases in Bali

Tempo
·
Jan 15

Stock Track | GeneDx Holdings Plummets 5.07% Intraday Amid Mixed Analyst Opinions

Stock Track
·
Jan 13

GeneDx Shares Down 2.5% After Announcing Preliminary Q4 Results, 2026 Outlook

THOMSON REUTERS
·
Jan 12

GeneDx Reports Preliminary Q4 Revenue; Issues 2026 Revenue Guidance

MT Newswires Live
·
Jan 12

Genedx Holdings Corp. unveils presentation highlighting advances in rare disease diagnosis and genomics-driven healthcare

Reuters
·
Jan 12

GeneDx reports preliminary Q4 revenue $121M, consensus $120.49M

TIPRANKS
·
Jan 12

GeneDx Projects 2026 Revenue of Up to $555 Million with Strong Exome and Genome Growth

Reuters
·
Jan 12

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

THOMSON REUTERS
·
Jan 12

GeneDx Holdings Corp - Expects 2025 Revenues of $427 Mln

THOMSON REUTERS
·
Jan 12

GeneDx Q4 Revenue USD 121 Million VS. Ibes Estimate USD 116.9 Million

THOMSON REUTERS
·
Jan 12

Fact Check: Superflu Is Not More Dangerous Than Covid-19

Tempo
·
Jan 11